Masaru Shimada

999 total citations · 1 hit paper
24 papers, 710 citations indexed

About

Masaru Shimada is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Masaru Shimada has authored 24 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Masaru Shimada's work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Masaru Shimada is often cited by papers focused on Virus-based gene therapy research (9 papers), HIV Research and Treatment (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Masaru Shimada collaborates with scholars based in Japan, United States and Bangladesh. Masaru Shimada's co-authors include Kenji Okuda, Takehiro Ura, Nobuhisa Mizuki, Akio Yamashita, Dennis M. Klinman, Yoshiyuki Wada, Hiroyuki Mizuguchi, Asami Kondo, Atsushi Yoshida and Xiao Tian Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Vaccine.

In The Last Decade

Masaru Shimada

23 papers receiving 698 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Developments in Viral Vector-Based Vaccines

2014 321 citations Takehiro Ura, Kenji Okuda et al. Vaccines profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaru Shimada Japan	12	319	219	166	144	135	24	710
Wuxiang Guan China	22	760 2.4×	405 1.8×	103 0.6×	242 1.7×	292 2.2×	48	1.3k
Pawan Kumar India	9	172 0.5×	80 0.4×	75 0.5×	46 0.3×	79 0.6×	40	466
Jens Vollmar Germany	16	207 0.6×	323 1.5×	280 1.7×	104 0.7×	643 4.8×	18	1.1k
Franck J. D. Mennechet France	17	202 0.6×	318 1.5×	486 2.9×	319 2.2×	365 2.7×	31	1.2k
Giada Mattiuzzo United Kingdom	18	399 1.3×	208 0.9×	133 0.8×	215 1.5×	232 1.7×	48	841
Claudia Sánchez-San Martín United States	14	334 1.0×	222 1.0×	80 0.5×	133 0.9×	180 1.3×	14	784
G. Saikumar India	18	240 0.8×	167 0.8×	31 0.2×	103 0.7×	119 0.9×	82	811
Sebastian Ols Sweden	12	374 1.2×	366 1.7×	399 2.4×	62 0.4×	130 1.0×	20	867
Tabea Binger Germany	13	979 3.1×	103 0.5×	61 0.4×	47 0.3×	202 1.5×	20	1.2k
Amy B. Barnum United States	6	195 0.6×	335 1.5×	248 1.5×	164 1.1×	90 0.7×	6	598

Countries citing papers authored by Masaru Shimada

Since Specialization

Citations

This map shows the geographic impact of Masaru Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Shimada more than expected).

Fields of papers citing papers by Masaru Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Shimada. The network helps show where Masaru Shimada may publish in the future.

Co-authorship network of co-authors of Masaru Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Shimada. A scholar is included among the top collaborators of Masaru Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Shimada. Masaru Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hossain, Md. Golzar, et al.. (2025). Impact of Viral Diseases on the Livestock Sector in Bangladesh. Veterinary Medicine International. 2025(1). 5492206–5492206.

Rahman, Md. Abdur, Md. Golzar Hossain, Jahangir Alam, et al.. (2025). First report of the emergence of novel sub-genotype XIII.2.3 of Newcastle disease virus in chickens from selected regions of Bangladesh. Infection Genetics and Evolution. 130. 105742–105742. 1 indexed citations

Ahammed, Tanvir, et al.. (2025). Evaluation of factors influencing self-medication practices with antibiotics and their impact on antimicrobial resistance among rural populations in Bangladesh. Microbial Pathogenesis. 207. 107848–107848. 1 indexed citations

Tsukamoto, Kosuke, Akio Yamashita, Masatoshi Maeki, et al.. (2024). Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types. Vaccines. 12(11). 1239–1239. 2 indexed citations

Saha, Sukumar, et al.. (2024). Clinical Application of Adenovirus (AdV): A Comprehensive Review. Viruses. 16(7). 1094–1094. 11 indexed citations

Hossain, Md. Golzar, Md. Alamin, Jahangir Alam, et al.. (2024). The first report of concurrent infection of hemorrhagic septicemia with foot and mouth disease in cattle in Bangladesh. Comparative Immunology Microbiology and Infectious Diseases. 115. 102272–102272. 1 indexed citations

Shimada, Masaru, Haibin Wang, Motohide Ichino, et al.. (2022). Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C. Gene Therapy. 29(10-11). 636–642. 7 indexed citations

Ito, Saori, Takehiro Ura, Jun Fukushima, et al.. (2021). Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles. Vaccine. 39(23). 3152–3160. 13 indexed citations

Shimada, Masaru, Akio Yamashita, Motohide Ichino, et al.. (2020). The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation. Scientific Reports. 10(1). 14195–14195. 23 indexed citations

10.

Ura, Takehiro, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, & Masaru Shimada. (2020). New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates. Vaccine. 39(2). 197–201. 62 indexed citations

11.

Tang, Jin Bo, Ya Fang Wu, Yi Cao, et al.. (2016). Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons. Scientific Reports. 6(1). 20643–20643. 67 indexed citations

12.

Shimada, Masaru, et al.. (2014). Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination. Vaccine. 32(40). 5198–5205. 2 indexed citations

13.

Shimada, Masaru, Shinya Abe, Toru Takahashi, et al.. (2013). Prophylaxis and Treatment of Alzheimer's Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein. PLoS ONE. 8(3). e57606–e57606. 21 indexed citations

14.

Shoji, Masaki, et al.. (2012). Immunogenic Comparison of Chimeric Adenovirus 5/35 Vector Carrying Optimized Human Immunodeficiency Virus Clade C Genes and Various Promoters. PLoS ONE. 7(1). e30302–e30302. 14 indexed citations

15.

Piboonpocanun, Surapon, Sunee Sirivichayakul, Supranee Buranapraditkun, et al.. (2010). Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen.. PubMed. 20(7). 582–90. 10 indexed citations

16.

Shimada, Masaru, Nao Jounai, Asami Kondo, et al.. (2010). DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity. Vaccine. 28(31). 4920–4927. 7 indexed citations

17.

Yashima, Sayaka, Atsushi Yoshida, Asami Kondo, et al.. (2010). Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells. Vaccine. 28(18). 3257–3264. 7 indexed citations

18.

Wang, HB, Asami Kondo, Atsushi Yoshida, et al.. (2009). Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys. Gene Therapy. 17(1). 4–13. 16 indexed citations

19.

Abe, Shinya, Kenji Okuda, Takehiro Ura, et al.. (2009). Adenovirus type 5 with modified hexons induces robust transgene‐specific immune responses in mice with pre‐existing immunity against adenovirus type 5. The Journal of Gene Medicine. 11(7). 570–579. 42 indexed citations

20.

Shimada, Masaru, HB Wang, Asami Kondo, et al.. (2008). Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy. Gene Therapy. 16(2). 218–228. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact